Use of Fluorescein Dye for the Removal of Brain Tumors

Status Completed

Clinical Trial Summary

Fluorescein is a dye agent that can be injected through an intravenous line. It has been shown to help tell the difference between brain tumor tissue and normal brain tissue when it is used together with a specialized filter on a microscope in the operating room. The investigators plan to study the use of fluorescein in the removal of brain tumors at a low dose.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Brain Neoplasms

Clinical Trial Details

NCT number	NCT02389530
Study type	Observational [Patient Registry]
Source	University of Pittsburgh
Contact
Status	Completed
Phase
Start date	May 2015
Completion date	June 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02810899` - Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy	Phase 4
Withdrawn	`NCT00977795` - A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors	Phase 1/Phase 2
Recruiting	`NCT00787982` - Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors	Phase 1/Phase 2
Withdrawn	`NCT00555984` - Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors	N/A
Completed	`NCT00038441` - Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas	Phase 1/Phase 2
Recruiting	`NCT03619694` - Role of MR Spectroscopy in Brain Tumors
Withdrawn	`NCT01236586` - RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia	Phase 1
Unknown status	`NCT02775136` - An Evaluation of a Non-invasive Brain Monitor	N/A
Completed	`NCT01244737` - FLT-PET Imaging of Brain Tumors in Children	Phase 2
Completed	`NCT00993057` - Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia	Early Phase 1
Terminated	`NCT00769093` - Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy	Phase 1
Completed	`NCT00392119` - MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors	Phase 1
Completed	`NCT00062478` - Study of Karenitecin (BNP1350) in Patients With Brain Tumors	Phase 2
Terminated	`NCT00038389` - Study of Vioxx and Radiation Therapy for Brainstem Glioma	Phase 1
Recruiting	`NCT05049148` - Platelets Activation in Brain Neoplasms	N/A
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Recruiting	`NCT04712721` - Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.	Early Phase 1
Completed	`NCT02881957` - Hypovitaminosis D in Neurocritical Patients	Phase 2/Phase 3
Terminated	`NCT01954576` - NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme	N/A
Recruiting	`NCT05538130` - A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors	Phase 1